These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 17409888)

  • 1. Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel.
    Fernandes MGO; Vilariça AS; Fernandes B; Camacho C; Saraiva C; Estevinho F; Novais E Bastos H; Lopes JM; Fidalgo P; Garrido P; Alves S; Silva S; Sequeira T; Barata F
    Pulmonology; 2024; 30(1):4-7. PubMed ID: 37210340
    [No Abstract]   [Full Text] [Related]  

  • 2. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.
    Travis WD; Brambilla E; Noguchi M; Nicholson AG; Geisinger K; Yatabe Y; Powell CA; Beer D; Riely G; Garg K; Austin JH; Rusch VW; Hirsch FR; Jett J; Yang PC; Gould M;
    Proc Am Thorac Soc; 2011 Sep; 8(5):381-5. PubMed ID: 21926387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. November--lung cancer awareness month!
    Hirsch FR
    J Thorac Oncol; 2010 Nov; 5(11):1719-20. PubMed ID: 20975370
    [No Abstract]   [Full Text] [Related]  

  • 4. Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology.
    Jalal SI; Riggs HD; Melnyk A; Richards D; Agarwala A; Neubauer M; Ansari R; Govindan R; Bruetman D; Fisher W; Breen T; Johnson CS; Yu M; Einhorn L; Hanna N
    Ann Oncol; 2012 Jul; 23(7):1730-8. PubMed ID: 22156624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers are here to stay for clinical research and standard care.
    Bunn PA; Hirsch FR; Doebele RC; Camidge DR; Varella-Garcia M; Franklin W
    J Thorac Oncol; 2010 Aug; 5(8):1113-5. PubMed ID: 20661083
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy.
    Hirsch FR; Herbst RS; Olsen C; Chansky K; Crowley J; Kelly K; Franklin WA; Bunn PA; Varella-Garcia M; Gandara DR
    J Clin Oncol; 2008 Jul; 26(20):3351-7. PubMed ID: 18612151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-small cell lung cancer.
    Ettinger DS; Akerley W; Bepler G; Chang A; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Feigenberg SJ; Figlin RA; Govindan R; Grannis FW; Jahan T; Jahanzeb M; Kessinger A; Komaki R; Kris MG; Langer CJ; Le QT; Martins R; Otterson GA; Patel JD; Robert F; Sugarbaker DJ; Wood DE
    J Natl Compr Canc Netw; 2008 Mar; 6(3):228-69. PubMed ID: 18377844
    [No Abstract]   [Full Text] [Related]  

  • 8. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.
    Bean J; Brennan C; Shih JY; Riely G; Viale A; Wang L; Chitale D; Motoi N; Szoke J; Broderick S; Balak M; Chang WC; Yu CJ; Gazdar A; Pass H; Rusch V; Gerald W; Huang SF; Yang PC; Miller V; Ladanyi M; Yang CH; Pao W
    Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20932-7. PubMed ID: 18093943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR inhibitors in the treatment of lung cancer.
    Hirsch FR
    Onkologie; 2007 Oct; 30(10):476. PubMed ID: 17890885
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluating the Prognostic Value of ERCC1 and Thymidylate Synthase Expression and the Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma Non-Small-Cell Lung Cancer.
    Lin CS; Liu TC; Lai JC; Yang SF; Tsao TC
    Int J Med Sci; 2017; 14(13):1410-1417. PubMed ID: 29200955
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Guo N; Zhang W; Zhang B; Li Y; Tang J; Li S; Zhao Y; Zhao Y; Xia H; Yu C
    Mol Clin Oncol; 2015 Sep; 3(5):1123-1128. PubMed ID: 26623063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.
    Kalikaki A; Koutsopoulos A; Trypaki M; Souglakos J; Stathopoulos E; Georgoulias V; Mavroudis D; Voutsina A
    Br J Cancer; 2008 Sep; 99(6):923-9. PubMed ID: 19238633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer.
    Dubey S; Stephenson P; Levy DE; Miller JA; Keller SM; Schiller JH; Johnson DH; Kolesar JM;
    J Thorac Oncol; 2006 Jun; 1(5):406-12. PubMed ID: 17409891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer.
    Tiseo M; Capelletti M; De Palma G; Franciosi V; Cavazzoni A; Mozzoni P; Alfieri RR; Goldoni M; Galetti M; Bortesi B; Bozzetti C; Loprevite M; Boni L; Camisa R; Rindi G; Petronini PG; Ardizzoni A
    J Thorac Oncol; 2008 Oct; 3(10):1104-11. PubMed ID: 18827605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer.
    Han SW; Jeon YK; Lee KH; Keam B; Hwang PG; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Heo DS; Bang YJ; Kim TY
    Pharmacogenet Genomics; 2007 May; 17(5):313-9. PubMed ID: 17429313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare mutations in non-small-cell lung cancer.
    D'Arcangelo M; D'Incecco A; Cappuzzo F
    Future Oncol; 2013 May; 9(5):699-711. PubMed ID: 23647298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer.
    Tan CS; Cho BC; Soo RA
    Lung Cancer; 2016 Mar; 93():59-68. PubMed ID: 26898616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR: a prognostic and/or a predictive marker?
    Hirsch FR
    J Thorac Oncol; 2006 Jun; 1(5):395-7. PubMed ID: 17409888
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.